文献速递血栓与止血

癌症相关血栓形成风险预测模型报告的标准化:国际血栓与止血学会科学标准化委员会止血与恶性肿瘤分委会通讯

Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy.
PubMed 文献 · J Thromb Haemost · 2022-05-30

该通讯基于对已发表癌症相关静脉血栓栓塞风险预测模型的文献检索与TRIPOD清单评估,发现TRIPOD发布前后30个条目的报告质量无显著改善(81% vs 75%,p=0.15),22项TRIPOD后研究中仅2项声明遵循TRIPOD。国际血栓与止血学会科学标准化委员会止血与恶性肿瘤分委会倡导从四方面标准化风险预测模型的报告。

要点

  • TRIPOD发布前后30个条目报告率无显著改善(81% vs 75%,p=0.15)。
  • 22项TRIPOD后研究中仅2项声明遵循TRIPOD。
  • 分委会倡导纳入TRIPOD清单、明确推导人群及样本量依据、明确预测因子、实施前外部验证。

核心结论

  • 国际血栓与止血学会科学标准化委员会止血与恶性肿瘤分委会倡导对癌症相关静脉血栓栓塞风险预测模型的四个关键要素进行标准化。

研究设计与样本

  • 对已发表的癌症相关静脉血栓栓塞风险预测模型进行文献检索,并采用TRIPOD清单评估每个模型,共评估29个风险预测模型的30个条目。

主要发现

  • TRIPOD发布后时代30个条目的报告率为81%,TRIPOD发布前时代为75%,改善无统计学显著(p=0.15)。
  • TRIPOD发布前时代报告率最低(<70%)的7个条目(标题、样本量、缺失数据处理、基线人口学、模型性能的方法与结果、补充资源)在TRIPOD发布后时代平均改善22%。
  • TRIPOD发布后时代发表的22项研究中仅2项声明遵循TRIPOD。

关键数值与推荐

  • 倡导标准化四个关键要素:(1)纳入TRIPOD清单;(2)明确定义推导人群并论证样本量;(3)明确定义预测因子;(4)实施前进行外部验证。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the development of the Khorana score to predict risk of cancer-associated venous thromboembolism (VTE), many modified and de novo risk prediction models (RPMs) have been proposed. Comparison of the prognostic performance across models requires comprehensive reporting and standardized methods for model development, validation and evaluation. To improve the standardization of RPM reporting, the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) tool was published in 2015. To better understand the quality of reporting and development of RPMs for cancer-associated VTE, we performed a literature search of published RPMs and assessed each model using the TRIPOD checklist. Our results yielded 29 RPMs for which 30 items were evaluated. There was a non-significant (p = 0.15) improvement in reporting of the 30 items in the post-TRIPOD era (81%) versus the pre-TRIPOD era (75%). Of seven items (title, sample size, missing data handling, baseline demographics, methods and results for model performance, and supplemental resources) with the lowest reporting in the pre-TRIPOD era (<70%), there was an average improvement of 22% in the post-TRIPOD era. Only two of the 22 studies published in the post-TRIPOD era acknowledged compliance with TRIPOD. Informed by the results of this assessment, the Scientific and Standardization Committee (SSC) Subcommittee on Hemostasis & Malignancy of the International Society on Thrombosis and Hemostasis (ISTH) advocates for standardization of four key elements of RPMs for cancer-associated VTE: (1) inclusion of the TRIPOD checklist, (2) clear definition of the derivation population, with justification of sample size, (3) clear definition of predictors, and (4) external validation prior to implementation.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Sanfilippo KM, Wang TF, Carrier M, et al. Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. J Thromb Haemost. 2022. PMID: 35635332. doi:10.1111/jth.15759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。